Leberresektionen wegen primärer lebermalignome Eigene ergebnisse und literaturanalyse

Zusammenfassung Im Rahmen einer retrospektiven Untersuchung wurden 50 Resektionen wegen primärer Lebermalignome, die vom 1. 6. 1979 bis zum 31. 12. 1991 an der Chirurgischen Universitätsklinik Köln durchgeführt wurden, analysiert. Die Resektionsrate betrug 28 %. Die Kliniksletalität betrug insgesamt 22 % und konnte in den letzten 5 Jahren auf 4% gesenkt werden. Die Ein-, Dreiund Fünfjahresüberlebensraten betrugen unter Einschluß der Kliniksletalität 55%, 30% und 24%. Wichtigster Prognosefaktor war die chirurgische Radikalität. In einer Literaturanalyse wurden die Ergebnisse von 8725 Leberresektionen wegen primärer Lebermalignome, die zwischen 1980 bis 1992 publiziert wurden, untersucht. Die Resektionsrate betrug im Durchschnitt 32 ± 17%. Die Kliniksletalität konnte von 15 ± 5% (Resektionen vor 1970) auf 6 ± 2% (Resektionen nach 1980) gesenkt werden. Die Ein-, Drei- und Fünfjahresüberlebensraten betrugen 66 ± 17%, 39 ± 15% und 27 ± 10%. Bis auf eine geringere Kliniksletalität asiatischer Studien (4 % vs. 7%) waren die Resektionsraten und Langzeitergebnisse von asiatischen, amerikanischen und europäischen Studien durchaus vergleichbar. Die Langzeitprognose wird in erster Linie durch die erreichte chirurgische Radikalität sowie die Größe und Ausdehnung des Tumors zum Zeitpunkt der Resektion beeinflußt. Die Effektivität adjuvanter Therapien ist noch nicht ausreichend untersucht.

---

Liver resection for primary liver tumors. Our own results and an analysis of the literature

In a retrospective study we analysed 50 resections for primary liver tumors performed between 1 July 1979 and 31 December 1991 at the Department of Surgery of the University of Cologne. The mean resectability rate was 28 %. Hospital mortality after resection was 22% and could be reduced to 4% during the last 4 years. The overall survival rates after 1, 3 and 5 years were 55%, 30% and 24% respectively. The surgical radicality is the most important prognostic factor. In a review of the literature the results of 8,725 resections for primary liver malignancies published between 1980 and 1992 were analyzed. The mean resectability rate was 32 ± 17%. The hospital mortality after resection could be reduced from 15 ± 5% (resections before 1970) to 6 ± 2 % (resections after 1980). The overall survival rates after 1, 3 and 5 years were 66 ± 17%, 39 ± 15% and 27 ± 10%, respectively. Apart from a lower hospital mortality in Asian studies (4 % vs. 7 %) the resection rates and long-term results of Asian, American and European studies were similar. Long-term prognosis predominantly depended on the surgical radicality and on the size and extension of the tumor at the point of resection. The effectivity of an adjuvant tumor therapy is not analyzed sufficiently.

     

基于SEER数据库建立小肝癌患者远处转移预测模型

目的 建立可有效预测小肝癌患者远处转移风险的列线图。方法 从SEER（Surveillance,Epidemiology,and End Results）数据库提取2010年1月至2016年12月诊断的5 595例小肝癌患者的临床病理资料,采用随机数字法按7:3分为训练组（n=3 915）和验证组（n=1 680）。对训练组采用单因素及多因素Logistic回归分析筛选影响远处转移的独立危险因素并构建小肝癌患者远处转移预测模型。采用受试者工作特征（ROC）曲线及校正曲线评估模型的预测准确性,采用决策曲线评价列线图的临床效用。结果 训练组多因素Logistic分析显示婚姻状况（HR 1.541,95%CI 1.182~2.010,P=0.001）、癌结节数目（HR 2.005,95%CI 1.483~2.710,P<0.001）、T分期（HR 2.076,95%CI 1.176~3.664,P=0.012）、N分期（HR 7.753,95%CI 5.349~11.238,P<0.001）、病理分化程度（HR 1.706,95%CI 1.098~2.652,P=0.018）、甲胎蛋白（HR 1.830,95%CI 1.313~2.550,P<0.001）是小肝癌远处转移的独立危险因素。训练组、验证组中ROC曲线下面积（AUC值）分别为0.805（95%CI 0.778~0.832）和0.829（95%CI 0.791~0.868）,校准曲线表明预测值与实际值有良好的一致性,决策曲线显示模型有良好的临床效用。结论 基于SEER数据库建立小肝癌患者远处转移的预测模型具有良好的预测准度,有助于外科医师评估患者远处转移风险,从而为患者提供个体化的诊疗。     

个人剂量监测中异常结果的调查与分析

目的 对2014—2017年本实验室个人剂量监测过程中出现的异常结果进行调查与原因分析。方法 放射工作人员佩戴热释光个人剂量计监测个人剂量当量H_P(10),对测量结果超过调查水平的进行统计分析。结果 2014—2017年,本实验室共出现40个单位69人次个人剂量监测结果异常,其中从事诊断放射学的占83%;剂量结果在1.25～5.00 mSv占54%;导致剂量结果异常的主要原因有剂量计佩戴不规范（67%）、原因不明（20%）、工作量增加（10%）和设备维修（占3.0%）等。结论 加强放射工作单位对放射工作人员的管理及放射防护培训,提高个人防护意识。     

Survival and prognostic factors for postoperative primary appendiceal cancer: a retrospective cohort study based on the Surveillance,Epidemiology, and End Results database

BackgroundThe factors affecting the postoperative survival of patients with primary appendiceal cancer (PAC) have yet to be fully explored. And there are no clear guidelines for adjuvant treatment after appendectomy. Whether chemotherapy can prolong patient survival after appendectomy, is critical in guiding postoperative medications. The majority of studies on appendiceal cancer are single case reports, and they focused on the incidence of appendiceal cancer. The present study aimed to investigate the survival characteristics of patients with primary appendiceal cancer after surgery using the Surveillance, Epidemiology, and End Results (SEER) database.MethodsThe data of 2,891 cases of primary appendiceal cancer between 2004 to 2015 were obtained from the SEER database and subjected to survival analysis using the Kaplan-Meier method and Cox proportional-hazards model. The annual percentage change (APC) was calculated using the weighted least squares method.ResultsThe overall age-adjusted incidence rate per 100,000 population steadily increased from 0.58 in 2004 to 1.63 in 2015. For patients who received chemotherapy, the median overall survival (OS) was 65 months and the 5-year OS rate was 51.9%, and for patients who did not receive chemotherapy or whose chemotherapy status was unknown, the median OS was not reached and the 5-year OS rate was 78.9%. Age [35< age <69: hazard radio (HR) =2.147; 95% confidence interval (CI): 1.442–3.197, P<0.001; age >69: HR =5.259; 95% CI: 3.485–7.937, P<0.001], race (White race: HR =0.728; 95% CI: 0.590–0.899, P=0.003), histologic type (mucinous neoplasm: HR =0.690; 95% CI: 0.580–0.821, P<0.001; malignant carcinoid: HR =0.657; 95% CI: 0.536–0.806, P<0.001), grade (II: HR =1.794; 95% CI: 1.471–2.187, P<0.001; III: HR =2.905; 95% CI: 2.318–3.640, P<0.001; IV: HR =3.128; 95% CI: 2.159–4.533, P<0.001), and stage (localized: HR =0.236; 95% CI: 0.194–0.287, P<0.001; regional: HR =0.425; 95% CI: 0.362–0.499, P<0.001) were identified as independent predictors of survival. And after adjusting for known factors (age, sex, race, tumor size, marital status, histologic type, grade, stage), chemotherapy (HR =1.220; 95% CI: 1.050–1.417, P=0.009) was revealed to be an independent indicator of poor prognosis.ConclusionsThere was an increasing trend in the incidence of appendiceal cancer in the United States between 2004 and 2015. Chemotherapy was revealed to be an independent indicator of poor prognosis, which provide valuable insight into the therapy of primary appendiceal cancer. Large clinical trials of chemotherapy and targeted therapy for appendiceal cancer are urgently needed.     

普通专科医师培训九项技能操作考核效果分析

目的强化、检验专科医师技能操作培训效果,使培训工作开展得扎实有效,为进一步提高培训质量,提出科学、合理、有针对性的改进措施。方法以2009年进院的43名硕士研究生学历医师作为实验组,进行一阶段（1年）9项技能操作培训。再以2008年进院的48名硕士研究生学历医师作为对照组,对照组未施加任何相关于预措施,对实验组在培训前和培训后各进行一次9项技能操作考核;同时,作为对照组也随之参加考核,并对两组的考核成绩进行统计。结果实验组9项技能操作培训考核后成绩均高于阶段考核前各项目成绩,且有统计学意义(P＜0.01),对照组9项技能操作阶段后考核成绩中7项较阶段考核前有所提高,但仅有2项提高值有统计学意义,此外,两组研究对象的两次考核成绩提高值对比,实验组各项成绩提高值均高于对照组,且比较有统计学意义(P＜0.01)。结论专科医师培训是提高青年医师临床实践技能的快速、有效方法。     

PDCA在住院医师规范化培训师资教学查房督导中的应用

目的探讨PDCA循环在师资教学查房督导中运用成效,充分发挥督导作用,从而提升师资教学查房质量。方法将2019年师资作为对照组,采用旧的教学查房督导方法,2020年师资作为实验组,在教学查房督导中采取PDCA循环,每季度循环1次,对比2组师资查房考核成绩。结果对照组师资教学查房成绩为86.1175±5.51864,实验组师资教学查房成绩为87.9536±4.20446,差异具有统计学意义(P<0.05);趋势图显示对照组第1季度至第4季度师资查房成绩分别为87.6、84.95、85.51、86.29,成绩无明显差异,而实验组中第1季度至第4季度师资查房成绩分别为86.8、87.32、88.36、90.15,成绩呈现季度递增。2年度教学查房共性失分点季度改变对比趋势图中显示,PDCA循环后英语教授、检查护理问题、病例特点总结得分呈现季度递增。结论将PDCA循环运用于在师资教学查房督导中,可以有效解决查房中存在的实际问题,使整改更具有目的性,有效提高整改质量,有助于稳步提升师资教学查房水平,具有重要参考意义。     

Treatment of herniated lumbar disc by percutaneous laser disc decompression combined with synchronous suction technique through syringe

Objective： To compare the outcomes of percutaneous laser disc decompression （PLDD） and PLDD with synchronous suction through syringe in the patients with herniated lumbar disc（HLD）. Methods： Forty-two patients with HLD on MRI and those who did not respond to conservative treatment for 6 weeks were randomly divided into group A and group B. In group A, the patients were treated with PLDD and those in group B with PLDD and synchronous suction through syringe. GaAIAS diode laser at 810 nm was used for the ablation in both groups. The treatment effect was evaluated by modified MacNab＇s criteria on the 7^th, 30^th and 90^th day. Results： Evaluated by modified MacNab＇s criteria, the percentages of the excellent and good cases in total patients treated for group B and A were 80.95% and 57.14% on the 7^th follow-up day, 85.71% and 66.67% on the 30^th follow-up day, and 95.24% and 71.43% on the 90^th follow-up day, respectively. Conclusion： Synchronous suction technique through syringe during PLDD improves the overall outcome in the treatment of herniated lumbar disc.     

2009～2010年济宁市流行性感冒监测分析

目的了解甲型H1N1流感疫情变化,指导流感防控。方法对流感监测哨点医院报告的流感样病例（ILI）和辖区内报告的暴发疫情进行描述性分析,应用Realtime RT—PER对流感样病例进行流感病毒核酸检测,阳性标本应用MDCK细胞进行病毒分离。结果2009年6月～2010年3月4所流感监测哨点医院共报告门诊病例总数590590例,流感样病例12067例,ILI％为2．04。流感样病例病毒核酸检测阳性544份,其中甲型H1N1流感病毒阳性194份,季节性甲型流感病毒阳性248份,季节性乙型流感病毒阳性102份;细胞培养病毒分离血凝测定阳性143株,其中甲型H1N1流感病毒119株,季节性甲型流感病毒4株,季节性乙型Victoria流感病毒20株,各型流感病毒季节性消长趋势明显。流感样病例暴发疫情22起,病原检测18起流感病毒核酸阳性,其中7起季节性甲型流感、10起甲型H1N1流感和1起季节性甲、乙型流感混合感染。结论流感样病例数与病原学监测结果基本吻合,可以用来反映流感活动的强弱,监测网络的敏感性还有待于进一步提高。     

Clinical presentation and prognosis of adenosquamous carcinoma of the pancreas – Matched-pair analysis with pancreatic ductal adenocarcinoma

IntroductionAdenosquamous carcinoma of the pancreas (ASCP) is a rare subtype of pancreatic adenocarcinoma. The aim of this study was to investigate the characteristics and outcomes of ASCP in comparison to pancreatic ductal adenocarcinoma (PDAC).Materials and methodsAll patients with ASCP treated between December 2001 and December 2017 were identified from a prospective database. Clinicopathological and follow-up data were analyzed. A nested case-control-study with matched-pair analysis was performed to compare overall survival of ASCP and PDAC.ResultsOf 4009 patients undergoing surgery for pancreatic adenocarcinoma 91 patients had ASCP. Compared to PDAC ASCP were larger (4.0 vs. 3.2 cm; p < 0.0001), more frequently involved lymph nodes (88% vs. 78%; p = 0.0216), more frequently showed poor differentiation (G3: 79% vs. 36%; p < 0.0001) and more frequently were located in the pancreatic tail (19% vs. 10%; p = 0.0179). Overall median post-resection-survival was shorter in ASCP (10.8 vs. 20.5 months in PDAC; p = 0.0085), but 5-year survival rates were comparable (18.2% vs. 17.5%). After matching for the unevenly distributed prognostic factors survival after resection of ASCP and PDAC was comparable (p = 0.8301). Localization in the head or several parts of the pancreas, high CA 19-9 levels, and M1 disease were independent predictors of survival in patients with ASCP.ConclusionASCP is more aggressive with poorer differentiation and higher rates of lymph node metastases compared to PDAC. In spite of a shorter median survival, 5-year survival rates after surgical resection of about 18% can be expected in ASCP and support resection as part of a multimodal therapy as the treatment of choice in this rare cancer.     

Malignant Cutaneous Adnexal Tumors and Role of SLNB

1. Download : Download high-res image (314KB)
2. Download : Download full-size image